Synergistic Activity of Anti-GD2 Antibody and CD47-Blockade for Immunotherapy of Neuroblastoma and Osteosarcoma |
The Board of Trustees of the Leland Stanford Junior University / Robbie Majzner, MD |
'A' Award Grants |
2019 |
California |
A Combinatorial Approach to Target the Tumor-Initiating and Transit Amplifying Cellular Subpopulations in Diffuse Intrinsic Pontine Glioma (DIPG) |
Stanford University / Michelle Monje, MD, PhD |
'A' Award Grants |
2011 |
California |
Targeting Metabolism in Alveolar Soft Part Sarcomagenesis |
Huntsman Cancer Institute / Kevin Jones, MD |
'A' Award Grants |
2013 |
Utah |
Mechanisms of PAX3-FOXO1 and HES3 Cooperation in Rhabdomyosarcoma |
Nationwide Children’s Hospital / Genevieve Kendall, PhD |
'A' Award Grants |
2018 |
Ohio |
DNA Damage Responses Coordinate Survival and Cell Death Switching In Lymphocytes |
Washington University / Jeffrey Bednarski, MD, PhD |
'A' Award Grants |
2013 |
Missouri |
Characterizing the Developmental Context of Pediatric Leukemia
|
Icahn School of Medicine at Mount Sinai / Elvin Wagenblast, PhD |
'A' Award Grants |
2022 |
New York |
Modulation of STING to enhance the efficacy of treatments for diffuse midline glioma |
Duke University / Zachary Reitman, MD/PhD |
'A' Award Grants |
2023 |
North Carolina |
Exploiting glypican diversity in neuroblastoma plasticity with bicistronic CAR T cell targeting |
Children’s Hospital of Philadelphia / Kristopher Bosse, MD |
'A' Award Grants |
2022 |
Pennsylvania |
Circulating Tumor Biomarkers: New Paradigms for Management of Neuroblastoma |
University of Chicago / Mark Applebaum, PhD |
'A' Award Grants |
2021 |
Illinois |
Pediatric Sarcoma, Rhabdomyosarcoma, and Mechanisms of Origin |
University of Texas Southwestern Medical Center / Rene Galindo |
'A' Award Grants |
2010 |
Texas |